OSVALDO LUIZ DA COSTA

Projetos de Pesquisa
Unidades Organizacionais
Cargo

Resultados de Busca

Agora exibindo 1 - 10 de 12
  • Resumo IPEN-doc 26556
    Improvements in the quality control of iridium-192 wire used in brachytherapy
    2011 - COSTA, OSVALDO L.; ZEITUNI, CARLOS A.; ROSTELATO, MARIA E.C.M.; MOURA, JOÃO A.; FEHER, ANSELMO; MOURA, EDUARDO S.; SOUZA, CARLA D.; SOMESSARI, SAMIR L.
    Brachytherapy is a method used in the treatment of cancerous tumors by ionizing radiation produced by sources introduced into the tumor area, this method seeks a more direct attack to the tumor, thereby maximizing the radiation dose to diseased tissue while minimizing the dose to healthy tissues (1). One of the radionuclides used in brachytherapy is iridium-192. The Radiation Technology Center (CTR) of the Nuclear and Energy Research Institute (IPEN) has produced commercially, since 1998, iridium-192 wires used in low dose rate (LDR) brachytherapy (2). To produce this radionuclide, firstly a iridium-platinum wire is irradiated in the nuclear reactor IEA-R1 for 30 hours with a neutron flux of 5 x 1013 ncm-2s-1, the wire is left to decay by 30 days to remove the main contaminants and then goes through a quality control before being sent to the hospital. In this quality control is checked the radiation homogeneity along each centimeter of the wire (3). To implement this procedure is used a device consisting of an ionization chamber surrounded by a lead shield with a small 1 cm wide slit, linked to the ionization chamber is a voltage source and a Keithley 617 electrometer, 2 minutes is the range used to measure the charge by the electrometer. The iridium wire is considered in accordance when there is no variation greater than 5% between the average measures and the maximum and minimum values. However, due to design features of the measurement system, the wire may appear to the detector through the slit in larger sizes than the ideal, improperly influencing the final quality control. This paper calculates the difference in size of these variations in profile and their influence on the final count, it compares the actual values obtained and describes the improvements made in quality control procedures that provided more accurate measurement data, analyzes the results and suggests changes in devices aimed at further improving the quality control of iridium-192 wires produced at IPEN and used in hospitals in Brazil.
  • Resumo IPEN-doc 27037
    Waste management protocols for Iridium-192 sources production laboratory used in cancer treatment
    2016 - ROSTELATO, MARIA E.C.M.; SOUZA, CARLA D. de; SOUZA, DAIANE C.B. de; ZEITUNI, CARLOS A.; TIEZZI, RODRIGO; COSTA, OSVALDO L. da; RODRIGUES, BRUNA T.; MOURA, JOÃO A.; FEHER, ANSELMO; SORGATTI, ANDERSON; MOURA, EDUARDO S. de; MARQUES, JOSE R. de O.; SANTOS, RAFAEL M. dos; KARAM JUNIOR, DIB
    Introduction: Brachytherapy is a form of treatment that uses radioactive seeds placed in contact or inside the region to be treated, maximizing the radiation dose inside the targeted areas. Iridium-192 is being used in brachytherapy since 1955. It presents emission energy in the “therapy region” (370keV) and is easily produced in a nuclear reactor (191Ir (n, γ) → 192Ir). Wires are an iridium-platinum alloy with 0.36 mm diameter and they can be cut in any needed length. They can be used in several types of cancer. The linear activity is between 1 mCi/cm (37 MBq/cm) and 4 mCi/cm (148 MBq/cm) with variations of 10% in 50 cm maximum. This activity values classified the treatment and low dose rate (0,4 à 2 Gy/h). The propose of this work is to present a waste management system in a cancer treatment radioactive sources production laboratory. Methodology and Results: The solid waste is previously characterized in the analysis phase. The contaminants are already known and they are insignificant due to their fast half- life. The iridium-192 half-life is 74.2 days, classified as very short half-life waste. The waste activity is adds to 8mCi (2.96x108 Bq) per wire. According to the CNEN-NN 6.08 standard, that presents the discharge levels, the limit is 1 kBq.kg-1 (2.7x10-5 mCi.kg-1). The radioactive waste generated during the I192 wires production has a weakly activity of 9.7 GBq.g-1. According to the standards, this activity is too high to be discarded into the environment. The waste must be managed following the ALARA principal using the R&R (retain e retard) system, that means, temporary storage and posterior discharge. Since every 4 months, maintenance is performed inside the hot cell used for production, the waste must be removed. Using the equation: 𝐴 = 𝐿 λ (1 − 𝑒−λt), the total calculated activity is 1.68 x 1016 Bq and 4.8 g mass at the end of each 4 months period. This amount is stored inside a shielding device that has 212.37 cm3 volume. The waste will take 9.8 years (calculated by 𝐴 = 𝐴0(𝑒−λt)) to decay to the discharge levels. To store 30 devices during 10 years, a space with 6,370 cm3 is necessary. The laboratory has enough space for this storage. Thus, the radioactive waste management can be performed through the R&R (retain and retard) system safely.
  • Artigo IPEN-doc 24374
    Waste management protocols for iridium-192 sources production laboratory used in cancer treatment in Brazil
    2017 - ROSTELATO, M.E.C.M.; SOUZA, D.C.B.; SOUZA, C.D.; ZEITUNI, C.A.; VICENTE, R.; COSTA, O.L.; RODRIGUES, B.T.; MOURA, J.A.; FEHER, A.; MOURA, E.S.; MARQUES, J.R.O.; CARVALHO, V.S.; NOGUEIRA, B.R.
    Objective: The iridium-192 wired sources production results in radioactive waste that needs to follow the guidelines. The aim of this study is to do a radioactive waste management of wastes from iridium-192 sources production laboratory used in cancer treatment in Brazil. Methods: The wire is acquired in an alloy form with 80% platinum and 20% iridium encapsulated with 100%. Electronic microscopy, X-ray fluorescence, and posterior iridium neutron activation (to determine contaminants) are performed to ensure quality. A 50-cm twisted wire is placed in an aluminum tube. The tube is sealed and place inside the reactor irradiator system and is left for decay during 30 hours to wait for the others undesired activation products to decay. The wire is prepared for treatment with 48 cm length with 192 mCi maximum activity. All the equipment use inside the hot cell must be calibrated every four months. All the waste must be removed from the hot cell. Results: The solid waste is previously characterized in the analysis phase. The contaminants are already known and they are insignificant due to their fast half-life. The iridium-192 half-life is 74.2 days, classified as very short half-life waste. The reminiscent activity is 8mCi. Conclusion: The radioactive waste generated during the I192 wires production is solid, was a short half-life and a weakly activity of 9.7 GBq.g-1. According to the standards, this activity is too high to be discarded into the environment (limit 10 Bq.g-1). The waste must be managed by the R&R (retain e retard) system.
  • Artigo IPEN-doc 24133
    Brazilian demand for iodine-125 seeds in cancer treatment after a decade of medical procedures
    2017 - COSTA, OSVALDO L. da; SOUZA, DAIANE C.B. de; FEHER, ANSELMO; MOURA, JOAO A.; SOUZA, CARLA D.; OLIVEIRA, HENRIQUE B. de; PELEIAS JUNIOR, FERNANDO S.; ZEITUNI, CARLOS A.; ROSTELATO, MARIA E.C.M.
  • Artigo IPEN-doc 22366
    Proposal for radioactive liquid waste management in brachytherapy sealed sources development laboratory
    2014 - SOUZA, C.D.; PELLEIAS JUNIOR, F.S.; ROSTELATO, M.E.C.M.; ZEITUNI, C.A.; BENEGA, M.A.G.; TIEZZI, R.; MATOS, F.R.; RODRIGUES, B.T.; OLIVEIRA, T.B.; FEHER, A.; MOURA, J.A.; COSTA, O.L.
  • Artigo IPEN-doc 21123
    Evaluation of aluminium capsules according to ISO 9978 to irradiation of gaseous samples in nuclear reactor
    2015 - COSTA, OSVALDO L. da; TIEZZI, RODRIGO; SOUZA, DAIANE C.B.; FEHER, ANSELMO; MOURA, JOAO A.; SOUZA, CARLA D.; MOURA, EDUARDO S.; OLIVEIRA, HENRIQUE B.; ZEITUNI, CARLOS A.; ROSTELATO, MARIA E.C.M.
  • Artigo IPEN-doc 21049
    Development of sealed radioactive sources immobilized in epoxy resin for verification of detectors used in nuclear medicine
    2015 - TIEZZI, RODRIGO; ROSTELATO, MARIA E.C.M.; NAGATOMI, HELIO R.; ZEITUNI, CARLOS A.; BENEGA, MARCOS A.; SOUZA, DAIANE B. de; COSTA, OSVALDO L. da; SOUZA, CARLA D.; RODRIGUES, BRUNA T.; SOUZA, ANDERSON S. de; PELEIAS JUNIOR, FERNANDO S.; SANTOS, RAFAEL M. dos; MELO, EMERSON R. de; KARAN JUNIOR, DIB
  • Artigo IPEN-doc 20407
    Study of the positioning influence in the water activity measurement during leak test of iodine-125 seeds
    2014 - MOURA, JOAO A.; FEHER, ANSELMO; ZEITUNI, CARLOS A.; ROSTELATO, MARIA E.C.M.; CALVO, WILSON A.P.; COSTA, OSWALDO L.; SOUZA, CARLA D.; JUNIOR, DIB K.; CAMARGO, ANDERSON R.
  • Artigo IPEN-doc 19425
    Influence of the profile of iridium-192 wire in measurements of quality control for use in brachytherapy
    2013 - COSTA, OSVALDO L.; ZEITUNI, CARLOS A.; ROSTELATO, MARIA E.C.M.; MOURA, JOAO A.; FEHER, ANSELMO; MOURA, EDUARDO S.; SOUZA, CARLA D.; SOMESSARI, SAMIR L.; PELEIAS JUNIOR, FERNANDO S.; MATTOS, FABIO R.
  • Artigo IPEN-doc 17032
    Development of an encapsulation method using plasma arc welding to produce iodine-125 seeds for brachytherapy
    2011 - FEHER, ANSELMO; CALVO, WILSON A.P.; ROSTELATO, MARIA E.C.M.; ZEITUNI, CARLOS A.; SOMESSARI, SAMIR L.; COSTA, OSVALDO L.; MOURA, JOAO A.; MOURA, EDUARDO S.; SOUZA, CARLA D.; RELA, PAULO R.